article thumbnail

Abstract 4145373: PREVALENCE OF NON-RHEUMATIC MITRAL STENOSIS IN CHRONIC KIDNEY DISEASE: NATIONAL IN-PATIENT SAMPLE ANALYSIS

Circulation

Background:There have been several studies postulating the association between Mitral valve stenosis (MS) and Chronic Kidney Disease (CKD). The prevalence of non rheumatic Mitral stenosis (MS) in the admission cohort was analyzed. The association between the conditions was statistically significant.

article thumbnail

Prevalence of Systemic Hypertension and the Effects of Cerebral Revascularization in Patients With Moyamoya Disease

Stroke: Vascular and Interventional Neurology

BACKGROUNDHypertension is often codiagnosed in patients with moyamoya disease (MMD), a progressive intracranial steno‐occlusive vasculopathy; this has principally been attributed to renal artery stenosis (up to 10%). 6.04]), kidney disease (OR, 18.98 [95% CI, 1.80–200.47]), 1.09]), body mass index (OR, 1.08 [95% CI, 1.03–1.13]),

article thumbnail

The failing heart and kidney: improving prevention and treatment

The British Journal of Cardiology

The Cardiorenal Forum’s recent 18 th Annual Scientific meeting looked at the latest updates in the failing heart and kidney.

article thumbnail

Temporal trends of aortic stenosis and comorbid chronic kidney disease in the province of Quebec, Canada

Open Heart

Objective To investigate temporal trends of chronic kidney disease (CKD) among patients with incident aortic stenosis (AS) and to compare these trends with that of a matched control population.

article thumbnail

Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study

Open Heart

Higher-predicted risk, compared with lower-predicted risk, was associated with incident chronic kidney disease (cumulative incidence per 1000 persons at 10 years 245.2; to 5.22; 4.32), peripheral vascular disease (44.6; to 6.98; 4.28), valvular heart disease (37.8; to 6.85; 4.54), aortic stenosis (18.7; 2.05, 2.00

article thumbnail

5 Most-Cited Takeaways From the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

Additionally, 10% of the global population suffers from chronic kidney disease , with diabetes and hypertension as significant risk factors. Disparities in care are also concerning, with diagnosed cardiometabolic diseases varying up to twofold among different racial and ethnic groups. In the U.S.,

CME 103